Amazon One’s technology combines palm and vein imagery for biometric matching that is 100 times more accurate than two irises, according to a March 3 company news release. To use it, patients hover their hand over the scanner to confirm their identity, eliminating the need for traditional identity-checking methods.
“One of NYU Langone’s goals is to leverage cutting-edge technology to enhance the patient experience,” Nader Mherabi, executive vice president and vice dean, chief digital and information officer at NYU Langone, said in the release. “We make all decisions with our patients in mind first and foremost, and we’re always looking for ways to improve their experience through technology. As with all new initiatives and technology of this scale, we will optimize over time and meet the needs of our patients.”
Palm scans are not stored on any Amazon One device. After a scan, the images are encrypted and sent to a highly secure environment in the AWS cloud. The technology is also integrated with Epic, though Amazon One does not receive or collect any medical information from providers. Patients can enroll online from home or at a system facility.
NYU Langone is rolling out the technology in mid-March to all its facilities and is expected to be completed in all locations by the end of 2025.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
